Glyscend Incorporated

0 followers


Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes.

Industries

Headquarters

Stage

Employees

Links

Org chart

Sapan Shah

Collapse
Thomas Jozefiak
Chief Scientific Officer
Ashish Nimgaonkar
Chief Medical Officer & Head, R&D
Mark Fineman
Chief Development Officer
Kevin Colbert
Senior Director, Operations & Strategy
Bob Soh
Director